Trillium Therapeutics Inc.

96 Skyway Avenue
Toronto, Ontario M9W 4Y9
Canada View Map >>

P: (416) 595-0627
F: (416) 595-5835
www.trilliumtherapeutics.com
Description
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The Company's lead program is a SIRPaFc antibody-like fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin. It is designed to act as a soluble decoy r... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company
Revenue
4545
Employees
28

Products & Services

therapies

Industries

Biotechnology, Drug Manufacturing & Research

Similar Companies

Allon Therapeutics Inc., iCo Therapeutics Inc., YM BioSciences Inc., Transition Therapeutics Inc.

Stock Market

NASDAQ: TRIL

SIC Codes

2834

NAICS Codes

325412

Recently updated profiles at this company (10 contacts available)

Tracey Mendonca
Accountant
Joyce Lin
Controller
Andrew Marshall
Drug Development Manager
Malik Slassi
Senior Vice President Discovery Research
Mark Regliszyn
Information Technology Manager
Meghan Irwin
Clinical Trial Manager
Tina Catalano
Associate Director, Drug Development
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory